{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:49:30Z","timestamp":1786117770813,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.steroids.2026.109810","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:44:47Z","timestamp":1780555487000},"page":"109810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Physicochemical characterisation of difluprednate and 6\u03b19\u03b1-difluoroprednisolone: Determination of solubility, pKa and LogP"],"prefix":"10.1016","volume":"233-234","author":[{"given":"Giulia","family":"Baluci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Immanuel","family":"Buhagiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Vella Szijj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everaldo","family":"Attard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9499-5875","authenticated-orcid":false,"given":"Nicolette","family":"Sammut Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2026.109810_b0005","unstructured":"U.S. Food & Drug Administration (FDA), Drug Approval Package Durezol (Difluprednate) Ophthalmic Emulsion. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/022212s000TOC.cfm, 2008 (accessed 14 July 2024)."},{"key":"10.1016\/j.steroids.2026.109810_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113483","article-title":"A multi- technique analytical approach for impurity profiling during synthesis: the case of difluprednate","volume":"190","author":"Sammut Bartolo","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.steroids.2026.109810_b0015","doi-asserted-by":"crossref","unstructured":"B. Kaviarasi, N. Rajana, Y.S. Pooja, A.N. Rajalakshmi, S.B. Singh, N.K. Mehra, Investigating the effectiveness of Difluprednate-Loaded core-shell lipid-polymeric hybrid nanoparticles for ocular delivery. 640 (2023) 123006. Doi: 10.1016\/j.ijpharm.2023.123006.","DOI":"10.1016\/j.ijpharm.2023.123006"},{"issue":"6","key":"10.1016\/j.steroids.2026.109810_b0020","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0731-7085(02)00515-0","article-title":"Analysis of an anti-inflammatory steroidal drug, difluprednate, in aqueous humor by combination of semi-micro HPLC and column switching method","volume":"30","author":"Yasueda","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.steroids.2026.109810_b0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2147\/OPTH.S6541","article-title":"Difluprednate for the prevention of ocular inflammation postsurgery: an update","volume":"5","author":"Donnenfeld","year":"2011","journal-title":"Clin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.steroids.2026.109810_b0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids","volume":"63","author":"Williams","year":"2018","journal-title":"Respir. Care"},{"key":"10.1016\/j.steroids.2026.109810_b0035","first-page":"381","article-title":"The role of difluprednate ophthalmic emulsion in clinical practice","volume":"3","author":"Jamal","year":"2009","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.steroids.2026.109810_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4137\/ACI.S12304","article-title":"Development of methods for the determination of pKa values","volume":"8","author":"Reijenga","year":"2013","journal-title":"Anal. Chem. Insights"},{"issue":"5729","key":"10.1016\/j.steroids.2026.109810_b0045","first-page":"1","article-title":"Collection of partition coefficients in hexadecyltrimethylammonium bromide, sodium cholate, and lithium perfluorooctanesulfonate micellar solutions: experimental determination and computational predictions","volume":"28","author":"Saranjam","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.steroids.2026.109810_b0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/chromsci\/bmac108","article-title":"HPLC-UV Method Development and Validation to Monitor Difluprednate Synthesis","volume":"61","author":"Sammut Bartolo","year":"2023","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.steroids.2026.109810_b0055","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology (Q2 R2), https:\/\/www.ich.org\/page\/quality-guidelines, 2023 (accessed 2025 Dec 12)."},{"key":"10.1016\/j.steroids.2026.109810_b0060","doi-asserted-by":"crossref","unstructured":"Am\u00e9zqueta S, Subirats X, Fuguet E, Ros\u00e9s M, R\u00e0fols C. Octanol-water partition constant, in: Handbooks in Separation Science: Liquid-phase extraction, Elsevier, 2020, pp 183-208. Doi: 10.1016\/C2018-0-00618-0.","DOI":"10.1016\/B978-0-12-816911-7.00006-2"},{"key":"10.1016\/j.steroids.2026.109810_b0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/138620709787581693","article-title":"Simultaneous determination of LogD, LogP, and pKa of drugs by using a reverse phase HPLC coupled with a 96-well Plate Auto Injector","volume":"12","author":"Chiang","year":"2009","journal-title":"Comb. Chem. High Throughput Screening"},{"key":"10.1016\/j.steroids.2026.109810_b0070","unstructured":"Tyner. Reagents, Buffers and Indicators. In: ACS Reagent Chemicals. America. American Chemical Society;1974. P. 95-106."},{"issue":"2","key":"10.1016\/j.steroids.2026.109810_b0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/10826070701738787","article-title":"HPLC determination of pKa of parabens and investigation on their lipophilicity parameters","volume":"31","author":"Angelov","year":"2008","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.steroids.2026.109810_b0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/ac0512103","article-title":"Simultaneous determination of pKa and lipophilicity by gradient RP-HPLC","volume":"78","author":"Wiczling","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.steroids.2026.109810_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.chroma.2008.10.085","article-title":"The application of gradient reversed-phase high-performance liquid chromatography to the pKa and logkw determination of polyprotic analytes","volume":"1214","author":"Wiczling","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.steroids.2026.109810_b0090","unstructured":"Novartis, Durezol\u00ae Product Monograph, https:\/\/www.novartis.com\/ca-en\/about\/products-list?search_api_fulltext=durezol&sort_by=title&sort_order=ASC 2023, (accessed 2025 Dec 12)."},{"key":"10.1016\/j.steroids.2026.109810_b0095","unstructured":"DrugBank Online, Difluprednate, https:\/\/go.drugbank.com\/drugs\/DB06781, (accessed 2025 Dec 12)."},{"key":"10.1016\/j.steroids.2026.109810_b0100","unstructured":"HMDB Online, Difluprednate, https:\/\/hmdb.ca\/metabolites\/HMDB0015676, (accessed 2025 Dec 12)."},{"issue":"6","key":"10.1016\/j.steroids.2026.109810_b0105","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.xphs.2019.01.003","article-title":"A kinetic approach to determining drug distribution in complex biphasic systems","volume":"108","author":"Dong","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.steroids.2026.109810_b0110","unstructured":"PubChem Online, 6-alpha-Fluoro-isopredone, https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/101859, (accessed 2025 Dec 12)."},{"key":"10.1016\/j.steroids.2026.109810_b0115","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10822-018-0167-1","article-title":"An explicit-solvent hybrid QM and MM approach for predicting pKa of small molecules in SAMPL6 challenge","volume":"32","author":"Prasad","year":"2018","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"3","key":"10.1016\/j.steroids.2026.109810_b0120","first-page":"699","article-title":"Prediction of pKa values for druglike molecules using semiempirical quantum chemical methods","volume":"121","author":"Jensen","year":"2017","journal-title":"Chem. A Eur. J."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X26000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X26000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:27:09Z","timestamp":1786026429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X26000723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"alternative-id":["S0039128X26000723"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2026.109810","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physicochemical characterisation of difluprednate and 6\u03b19\u03b1-difluoroprednisolone: Determination of solubility, pKa and LogP","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2026.109810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109810"}}